Peter Greenleaf

Companies

• Pelthos Therapeutics Inc.Board member Jul 7, 2025 to now¹
• Aurinia Pharmaceuticals Inc.Board member Jan 4, 2021 to now²
• Aurinia Pharmaceuticals Inc.Chief executive officer Jan 4, 2021 to Jun 2, 2026²
• ANTARES PHARMA, INC.Board member Dec 14, 2018 to May 26, 2022³
• BIODELIVERY SCIENCES INTERNATIONAL INCBoard member May 23, 2018 to Mar 22, 2022⁴
• Avalo Therapeutics, Inc.Board member May 16, 2017 to Oct 3, 2019⁵
• Avalo Therapeutics, Inc.Chief executive officer Mar 29, 2018 to Apr 2, 2019⁶
• KIORA PHARMACEUTICALS INCBoard member Jul 19, 2018 to Feb 5, 2019⁷
• Sucampo PharmaceuticalsChief executive officer Mar 5, 2014 to Feb 13, 2018⁸
• Savara IncBoard member Nov 9, 2015 to Jan 23, 2017⁹
• SYNLOGIC, INC.Board member Mar 2, 2016 to Sep 6, 2016¹⁰
• Sucampo PharmaceuticalsBoard member Mar 5, 2014 to Sep 15, 2014⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAurinia Pharmaceuticals Inc. AUPH1,840,379 shares¹¹$30.4M at $16.51Mar 2, 2026
• PTPelthos Therapeutics Inc. PTHS23,884 shares¹²$482.5K at $20.20Jul 2, 2026
• APANTARES PHARMA, INC.0 shares¹³May 24, 2022
• BSBIODELIVERY SCIENCES INTERNATIONAL INC0 shares¹⁴Mar 22, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 2, 2026Sold 85 shares at $27.27 of Pelthos Therapeutics Inc.¹²
• Jul 2, 2026Sold 712 shares at $26.00 of Pelthos Therapeutics Inc.¹²
• Apr 2, 2026Sold 377 shares at $21.36 of Pelthos Therapeutics Inc.¹⁵
• Apr 2, 2026Sold 420 shares at $20.52 of Pelthos Therapeutics Inc.¹⁵
• Mar 2, 2026Shares withheld for tax 100,890 shares at $14.21 of Aurinia Pharmaceuticals Inc.¹¹
• Feb 27, 2026Granted 196,403 shares of Aurinia Pharmaceuticals Inc.¹¹
• Feb 20, 2026Shares withheld for tax 100,171 shares at $14.40 of Aurinia Pharmaceuticals Inc.¹⁶
• Jan 2, 2026Shares withheld for tax 113,169 shares at $15.95 of Aurinia Pharmaceuticals Inc.¹⁷
• Jan 2, 2026Granted 165,384 shares of Aurinia Pharmaceuticals Inc.¹⁷
• Jul 2, 2025Granted 25,478 shares of Pelthos Therapeutics Inc.¹⁸
• Mar 4, 2025Sold 164,947 shares at $7.92 of Aurinia Pharmaceuticals Inc.¹⁹
• Mar 3, 2025Sold 195,593 shares at $8.00 of Aurinia Pharmaceuticals Inc.¹⁹
• Mar 3, 2025Granted 333,705 shares of Aurinia Pharmaceuticals Inc.¹⁹
• Feb 28, 2025Granted 290,728 shares of Aurinia Pharmaceuticals Inc.¹⁹
• Mar 6, 2024Sold 126,981 shares at $5.60 of Aurinia Pharmaceuticals Inc.²⁰
• Feb 20, 2024Granted 661,538 shares of Aurinia Pharmaceuticals Inc.²¹
• Mar 2, 2023Sold 32,750 shares at $8.94 of Aurinia Pharmaceuticals Inc.²²
• Mar 2, 2023Granted 667,407 shares of Aurinia Pharmaceuticals Inc.²²
• Mar 2, 2023Sold 33,047 shares at $8.78 of Aurinia Pharmaceuticals Inc.²³
• May 24, 2022Returned to company 49,425 shares at $5.60 of ANTARES PHARMA, INC.¹³
• May 24, 2022Returned to company 30,220 shares at $5.60 of ANTARES PHARMA, INC.¹³
• Mar 22, 2022Other 105,034 shares of BIODELIVERY SCIENCES INTERNATIONAL INC¹⁴
• Mar 2, 2022Sold 9,068 shares at $12.01 of Aurinia Pharmaceuticals Inc.²⁴
• Mar 2, 2022Granted 28,300 shares of Aurinia Pharmaceuticals Inc.²⁴
• Jan 27, 2022Exercised options 10,246 shares of BIODELIVERY SCIENCES INTERNATIONAL INC²⁵